Testing the NKT cell hypothesis in lenalidomide-treated myelodysplastic syndrome patients
AC Chan, P Neeson, E Leeansyah, K Tainton, H Quach, HM Prince, DI Godfrey, D Ritchie, SP Berzins
Leukemia | NATURE PUBLISHING GROUP | Published : 2010
Awarded by National Health and Medical Research Council (NHMRC)
We gratefully acknowledge the participation of patients and blood donors in the study, and the contributions of Sharyn Meadows and Amanda Marshall (research nurses), Dirk Honemann and Melita Kenealy (clinical fellows), Rhonda Holdsworth (Australian Red Cross Blood Bank) and Kon Kyparissoudis (research assistant). We acknowledge the generous funding of this study by the National Health and Medical Research Council (NHMRC), Project Grant (No. 454363). We also acknowledge the following funding support: SPB is supported by an NHMRC Career Development Award; DIG is supported by an NHMRC Program Grant (No. 251608, renewed as No. 454569) and an NHMRC Research Fellowship.